Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
EV/Core EBITDA

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 8.759.5238.6721.1913.71

What is the latest EV/Core EBITDA ratio of NATCO PHARMA ?

The latest EV/Core EBITDA ratio of NATCO PHARMA is 8.75 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20248.75
Mar20239.52
Mar202238.67
Mar202121.19
Mar202013.71

How is EV/Core EBITDA of NATCO PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 8.75
-8.09
Mar2023 9.52
-75.38
Mar2022 38.67
82.49
Mar2021 21.19
54.56
Mar2020 13.71 -

Other Financial Ratios of NATCO PHARMA


Compare EV/Core EBITDA ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹23,617.9 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses